Clinical Trial Update: ImmunoPET Targeting Trophoblast Cell-surface Antigen 2 (Trop-2) in Craniopharyngioma Patients [NA]

View source ↗

Summary

A clinical trial update describing an ImmunoPET imaging agent that targets Trop-2 for craniopharyngioma, with recruitment ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Craniopharyngioma

Snippet

Sponsor: Deling Li | Conditions: Craniopharyngioma | NA | Status: RECRUITING